Anita Ryningen

2.0k citations

45 papers · 1.6k indexed · h-index 24

Hematology top 1%
- Acute Myeloid Leukemia Research 18
- Hematopoietic Stem Cell Transplantation 7
- Platelet Disorders and Treatments 6
- Multiple Myeloma Research and Treatments 5
Oncology top 5%
- Chemokine receptors and signaling 6
Molecular Biology top 10%
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 6
Genetics top 5%
Cancer Research top 10%
Immunology
- Immune cells in cancer 6

Co-authors: Øystein Bruserud Bjørn Tore Gjertsen Elisabeth Ersvær Camilla Stapnes Thomas Arnesen Darina Gromyko Jan Erik Varhaug Kimberley Joanne Hatfield
Cited by: Hematology Oncology Molecular Biology
Partner nations: Norway United States France

In The Last Decade

Anita Ryningen

44 papers receiving 1.6k citations

Peers

Countries citing papers authored by Anita Ryningen

Since Specialization

Citations

This map shows the geographic impact of Anita Ryningen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Ryningen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Ryningen more than expected).

Fields of papers citing papers by Anita Ryningen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Ryningen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Ryningen. The network helps show where Anita Ryningen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anita Ryningen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anita Ryningen Line = papers co-authored together Anita Ryningen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acute response in circulating microRNAs following a single bout of short-sprint and heavy strength training in well-trained cyclists Anita Ryningen,Kari Rostad,Elisabeth Ersvær,Gry Sjøholt,Gøran Paulsen,Hilde Gundersen,Morten Kristoffersen,Lise Bjørkhaug	2024	0
2	Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients Ida Marie Rundgren,Elisabeth Ersvær,Aymen Ahmed,Anita Ryningen,Øystein Bruserud	2019	8
3	Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood Ida Marie Rundgren,Øystein Bruserud,Anita Ryningen,Elisabeth Ersvær	2018	17
4	Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles Håkon Reikvam,Anita Ryningen,Lars Rune Sæterdal,Ina Nepstad,Brynjar Foss,Øystein Bruserud	2014	9
5	Depletion of the human N^α‐terminal acetyltransferase A induces p53‐dependent apoptosis and p53‐independent growth inhibition Darina Gromyko,Thomas Arnesen,Anita Ryningen,Jan Erik Varhaug,Johan R. Lillehaug	2010	39
6	In Vitro Induction of a Dendritic Cell Phenotype in Primary Human Acute Myelogenous Leukemia (AML) Blasts Alters the Chemokine Release Profile and Increases the Levels of T Cell Chemotactic CCL17 and CCL22 Astrid Marta Olsnes,Anita Ryningen,Elisabeth Ersvær,Øystein Bruserud	2008	12
7	A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid Anita Ryningen,Camilla Stapnes,Philippe Lassalle,Matthias Corbascio,Bjørn Tore Gjertsen,Øystein Bruserud	2008	46
8	Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells Øystein Bruserud,Anita Ryningen,Astrid Marta Olsnes,Laila Stordrange,Anne M. Øyan,Karl H. Kalland,Bjørn Tore Gjertsen	2007	118
9	Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels Kimberley Joanne Hatfield,Randi Hovland,Anne M. Øyan,Karl‐Henning Kalland,Anita Ryningen,Bjørn Tore Gjertsen,Øystein Bruserud	2007	47
10	Epigenetic Targeting in Acute Myeloid Leukemia: Use of Flow Cytometry in Monitoring Therapeutic Effects Anita Ryningen,Øystein Bruserud	2007	3
11	Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML Øystein Bruserud,Camilla Stapnes,Karl Johan Tronstad,Anita Ryningen,Nina Ånensen,Bjørn Tore Gjertsen	2006	40
12	Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90 Anita Ryningen,Elisabeth Ersvær,Anne M. Øyan,Karl‐Henning Kalland,Olav Karsten Vintermyr,Bjørn Tore Gjertsen,Øystein Bruserud	2006	52
13	In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8 Anita Ryningen,Line Wergeland,Nils Glenjen,Bjørn Tore Gjertsen,Øystein Bruserud	2004	61
14	In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts Nils Glenjen,Elisabeth Ersvær,Anita Ryningen,Øystein Bruserud	2004	14
15	In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines Øystein Bruserud,Nils Glenjen,Anita Ryningen,Elling Ulvestad	2003	24
16	Effects of angiogenic regulators on in vitro proliferation and cytokine secretion by native human acute myelogenous leukemia blasts Øystein Bruserud,Nils Glenjen,Anita Ryningen	2003	13
17	Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets Anita Ryningen,Baard Olav Jensen,Holm Holmsen	1998	25
18	Thrombin per se Does Not Induce Tyrosine Protein Phosphorylation in Human Platelets as Judged by Western Blotting, While Collagen Does: The Significance of Synergistic, Autocrine Stimulation Anita Ryningen,Holm Holmsen	1998	15
19	Role of autocrine stimulation for the effects of cyclic AMP on protein and lipid phosphorylation in platelets activated by particles Anita Ryningen,Holm Holmsen	1998	6
20	Differential secretion of blood platelet storage granules Mohammad Reza Mirlashari,Anita Ryningen,Håvard Mikkelsen,Miriam H. Fukami	1996	17

About Anita Ryningen

Anita Ryningen is a scholar working on Hematology, Immunology and Oncology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (7 papers), Platelet Disorders and Treatments (6 papers), Chemokine receptors and signaling (6 papers), Ubiquitin and proteasome pathways (6 papers), Immune cells in cancer (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (686 citations), Oncology (624 citations) and Molecular Biology (1.0k citations). Anita Ryningen has collaborated with scholars based in Norway, United States and France. Frequent co-authors include Øystein Bruserud, Bjørn Tore Gjertsen, Elisabeth Ersvær, Camilla Stapnes, Thomas Arnesen, Darina Gromyko, Jan Erik Varhaug, Kimberley Joanne Hatfield, Nils Glenjen and Kristian K. Starheim.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact